NCT03873610Completed
Resiliency Training in Adolescents With NF1 and NF2
Resiliency Training in Adolescents With NF1 and NF2; A Randomized Controlled Trial Via Secure Live Video Conferencing to Improve Emotional, Social and Physical Function
Source: ClinicalTrials.gov · Last updated 11 Jun 2026
Brief summary (registry, in English)
This randomized controlled trial for resiliency training in adolescents with Neurofibromatosis 1 and Neurofibromatosis 2 via secure live video to determine the efficacy two stress and symptom management programs. Both programs are 8 week group programs.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 196 (actual)
- First submitted
- 12 Mar 2019
- Start date
- 15 Dec 2019
- Primary completion date
- 20 Feb 2026
- Lead sponsor
- Massachusetts General Hospital
- NCT number
- NCT03873610
What you commit to
- Study type: Interventional
- Participants enrolled: 196
- From 15 Dec 2019 to the primary completion date, 20 Feb 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Recent (within past 3 months) change in antidepressant medication
- Recent participation in cognitive behavioral therapy or relaxation therapy (within past 3 months)
Other illness
- Has significant mental health diagnosis requiring immediate treatment (e.g., untreated bipolar disorder, psychotic disorder, active substance dependence)
Other
- Has major medical co-morbidity not NF related expected to worsen in the next 12 months
- Unable or unwilling to complete assessments electronically via REDCap
- Unable or unwilling to participate in group videoconferencing sessions
- Unable or unwilling to participate along with at least 1 parent in a video screening session
Who the study is looking for
- Has a diagnosis of NF1 or NF2 and is between the ages of 12-17
- Is capable of completing and fully understanding the informed consent process/assent and the study procedures and assessments in English; has parental approval for participation
- English speaking and at least a 3rd grade self-reported and parent reported reading level
- Self reported/parent reported difficulties coping with stress and NF symptoms
Age in the registry: 12 years to 17 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Massachusetts General Hospital Coordinator of this site? Confirm its status | Boston | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.